We speculate that even if the major players, such as MBNL1 are corrected, other disease modifiers misregulated in DM1 such as Stau1, may continue to contribute to the pathology, perhaps through its role in alternative splicing. Here, MBNL1 is linked to myotonic dystrophy type 1.